About 4 in 10 Pharma Clinical Trials Are Phase 1; Oncology Leads, CRO Revenue Tops 1 Trillion KRW
AI 요약 정보
- Korea National Enterprise for Clinical Trials: Phase 1 36.5%
- Cancer drug trials lead therapeutic areas at 20.9%
- 81 South Korean CROs post 1.0416 trillion KRW in sales